PRE-MARKET INDIAN STOCKS NEWS: Aurobindo Pharma (ARBP IS) Q3 (INR) profit rose 7.6% Y/Y to 9.1bln, rev. rose 8.4% Y/Y to 86.5bln

Aurobindo Pharma's Q3 results show a year-on-year profit increase of 7.6% and revenue growth of 8.4%, which suggests steady operational performance in a challenging market.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Chair of SK Hynix (000660 KS) parent SK Group is said to meet with NVIDIA (NVDA) CEO Huang

Japan sells JPY 250bln 10yr I/L JGB; b/c 3.38x, (prev. 3.46x), yield at lowest accepted price 0.458% (prev. 0.113%)

PRE-MARKET INDIAN STOCKS NEWS: Aurobindo Pharma (ARBP IS) Q3 (INR) profit rose 7.6% Y/Y to 9.1bln, rev. rose 8.4% Y/Y to 86.5bln

[MARKET ANALYSIS] Asia-Pac stocks mostly take impetus from the continued tech-rebound stateside

China’s embassy in London says it has consistently opposed UK interference in China’s internal affairs, including the BNO issue

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Aurobindo Pharma (ARBP IS) - Co. Q3 (INR) profit rose 7.6% Y/Y to 9.1bln, rev. rose 8.4% Y/Y to 86.5bln. (Moneycontrol)

BSE (BSE IS) - Co. Q3 (INR) profit rose 174% Y/Y to 6.0bln, rev. rose 62% Y/Y to 12.4bln. (Moneycontrol)

Marico (MRCO IS) - Co. unit entered into definitive agreements to make a strategic investment in Vietnam-incorporated Skinetiq Joint Stock Company. (Moneycontrol)

Pfizer Ltd (PFIZER IS) - Co. Q3 (INR) profit rose 11.2% Y/Y to 1.4bln, rev. rose 19.9% Y/Y to 6.5bln. (Moneycontrol)

Context

While the numbers are positive, the growth rates are relatively modest and could indicate that the company is facing headwinds, particularly in comparison to other firms in the sector, such as Pfizer, which reported stronger revenue growth. This may influence investor sentiment regarding the stock in today's trading session, as they assess its competitive position.

Related headlines

The whole workspace, free to try.

Try it free